Torrent Said To Offer Elder $270 Million For Domestic Drug Business
This article was originally published in PharmAsia News
Torrent Pharma has jumped in where Sanofi left off and is said to be in advanced negotiations to buy the domestic business of Elder Pharma, offering $270.2 million, well under the France maker's $351 million.
You may also be interested in...
In this week’s podcast, Medtech Insight's managing editor Marion Webb has an update from the virtual HLTH panel discussions on telehealth and robotics. Deputy editor Reed Miller discusses trial results from Boston Scientific’s next-generation Accurate neo2 self-expanding aortic valve presented during the Transcatheter Cardiovascular Therapeutics (TCT) meeting.
The rare disease-focused firm will pay $90m up front to acquire Orphan Technologies and its Phase I/II enzyme replacement therapy for homocystinuria. Earnouts up to $427m are possible as well.